GO:0051128 | regulation of cellular component organization | 38.46% (25/65) | 2.73 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 56.92% (37/65) | 1.72 | 0.0 | 0.0 |
GO:0048522 | positive regulation of cellular process | 49.23% (32/65) | 1.83 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 69.23% (45/65) | 1.25 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 52.31% (34/65) | 1.68 | 0.0 | 0.0 |
GO:0010564 | regulation of cell cycle process | 21.54% (14/65) | 3.5 | 0.0 | 0.0 |
GO:0051726 | regulation of cell cycle | 24.62% (16/65) | 3.13 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 50.77% (33/65) | 1.68 | 0.0 | 0.0 |
GO:0010604 | positive regulation of macromolecule metabolic process | 36.92% (24/65) | 2.14 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 47.69% (31/65) | 1.71 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 49.23% (32/65) | 1.66 | 0.0 | 0.0 |
GO:0032502 | developmental process | 64.62% (42/65) | 1.26 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 53.85% (35/65) | 1.49 | 0.0 | 0.0 |
GO:0009893 | positive regulation of metabolic process | 38.46% (25/65) | 2.0 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 70.77% (46/65) | 1.08 | 0.0 | 0.0 |
GO:0031325 | positive regulation of cellular metabolic process | 33.85% (22/65) | 2.03 | 0.0 | 1e-06 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 38.46% (25/65) | 1.84 | 0.0 | 1e-06 |
GO:0043170 | macromolecule metabolic process | 55.38% (36/65) | 1.31 | 0.0 | 1e-06 |
GO:0010468 | regulation of gene expression | 41.54% (27/65) | 1.7 | 0.0 | 1e-06 |
GO:0051716 | cellular response to stimulus | 44.62% (29/65) | 1.6 | 0.0 | 1e-06 |
GO:0140096 | catalytic activity, acting on a protein | 36.92% (24/65) | 1.84 | 0.0 | 1e-06 |
GO:0048523 | negative regulation of cellular process | 38.46% (25/65) | 1.78 | 0.0 | 1e-06 |
GO:1902275 | regulation of chromatin organization | 9.23% (6/65) | 5.25 | 0.0 | 1e-06 |
GO:0048519 | negative regulation of biological process | 44.62% (29/65) | 1.54 | 0.0 | 2e-06 |
GO:0065007 | biological regulation | 70.77% (46/65) | 0.95 | 0.0 | 2e-06 |
GO:0030030 | cell projection organization | 13.85% (9/65) | 3.69 | 0.0 | 3e-06 |
GO:0033043 | regulation of organelle organization | 18.46% (12/65) | 2.96 | 0.0 | 3e-06 |
GO:0090597 | nematode male tail mating organ morphogenesis | 4.62% (3/65) | 8.5 | 0.0 | 3e-06 |
GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I | 4.62% (3/65) | 8.5 | 0.0 | 3e-06 |
GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type II | 4.62% (3/65) | 8.5 | 0.0 | 3e-06 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 30.77% (20/65) | 1.98 | 0.0 | 4e-06 |
GO:0006996 | organelle organization | 30.77% (20/65) | 1.98 | 0.0 | 4e-06 |
GO:0016043 | cellular component organization | 44.62% (29/65) | 1.45 | 0.0 | 5e-06 |
GO:1903046 | meiotic cell cycle process | 15.38% (10/65) | 3.23 | 0.0 | 7e-06 |
GO:0051252 | regulation of RNA metabolic process | 33.85% (22/65) | 1.77 | 0.0 | 8e-06 |
GO:0048808 | male genitalia morphogenesis | 4.62% (3/65) | 8.01 | 0.0 | 9e-06 |
GO:0048015 | phosphatidylinositol-mediated signaling | 6.15% (4/65) | 6.33 | 0.0 | 1.1e-05 |
GO:0048017 | inositol lipid-mediated signaling | 6.15% (4/65) | 6.33 | 0.0 | 1.1e-05 |
GO:0043412 | macromolecule modification | 36.92% (24/65) | 1.62 | 0.0 | 1.1e-05 |
GO:0036211 | protein modification process | 33.85% (22/65) | 1.73 | 0.0 | 1.2e-05 |
GO:0033554 | cellular response to stress | 32.31% (21/65) | 1.77 | 0.0 | 1.6e-05 |
GO:0071840 | cellular component organization or biogenesis | 44.62% (29/65) | 1.36 | 0.0 | 1.6e-05 |
GO:0009887 | animal organ morphogenesis | 10.77% (7/65) | 3.98 | 0.0 | 1.6e-05 |
GO:0032879 | regulation of localization | 23.08% (15/65) | 2.27 | 0.0 | 1.7e-05 |
GO:0005942 | phosphatidylinositol 3-kinase complex | 4.62% (3/65) | 7.65 | 0.0 | 1.7e-05 |
GO:0035032 | phosphatidylinositol 3-kinase complex, class III | 4.62% (3/65) | 7.65 | 0.0 | 1.7e-05 |
GO:0006974 | cellular response to DNA damage stimulus | 16.92% (11/65) | 2.84 | 0.0 | 1.7e-05 |
GO:0032991 | protein-containing complex | 36.92% (24/65) | 1.58 | 0.0 | 1.7e-05 |
GO:0051050 | positive regulation of transport | 13.85% (9/65) | 3.24 | 0.0 | 1.9e-05 |
GO:0043228 | non-membrane-bounded organelle | 30.77% (20/65) | 1.8 | 0.0 | 1.9e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 30.77% (20/65) | 1.8 | 0.0 | 1.9e-05 |
GO:0000803 | sex chromosome | 6.15% (4/65) | 6.02 | 0.0 | 2e-05 |
GO:0010556 | regulation of macromolecule biosynthetic process | 33.85% (22/65) | 1.67 | 0.0 | 2e-05 |
GO:0009653 | anatomical structure morphogenesis | 30.77% (20/65) | 1.79 | 1e-06 | 2.1e-05 |
GO:0090598 | male anatomical structure morphogenesis | 4.62% (3/65) | 7.5 | 1e-06 | 2.1e-05 |
GO:0010605 | negative regulation of macromolecule metabolic process | 27.69% (18/65) | 1.93 | 1e-06 | 2.2e-05 |
GO:0090596 | sensory organ morphogenesis | 6.15% (4/65) | 5.87 | 1e-06 | 2.6e-05 |
GO:0033044 | regulation of chromosome organization | 10.77% (7/65) | 3.82 | 1e-06 | 2.6e-05 |
GO:0048869 | cellular developmental process | 27.69% (18/65) | 1.89 | 1e-06 | 3.1e-05 |
GO:0120036 | plasma membrane bounded cell projection organization | 10.77% (7/65) | 3.75 | 1e-06 | 3.3e-05 |
GO:0032465 | regulation of cytokinesis | 7.69% (5/65) | 4.79 | 1e-06 | 4e-05 |
GO:0032467 | positive regulation of cytokinesis | 6.15% (4/65) | 5.59 | 2e-06 | 5.4e-05 |
GO:0031935 | obsolete regulation of chromatin silencing | 4.62% (3/65) | 7.01 | 2e-06 | 5.5e-05 |
GO:0006259 | DNA metabolic process | 16.92% (11/65) | 2.6 | 2e-06 | 5.8e-05 |
GO:0019538 | protein metabolic process | 36.92% (24/65) | 1.46 | 2e-06 | 5.9e-05 |
GO:0070727 | cellular macromolecule localization | 21.54% (14/65) | 2.18 | 2e-06 | 5.9e-05 |
GO:0048513 | animal organ development | 16.92% (11/65) | 2.58 | 2e-06 | 6.5e-05 |
GO:0060341 | regulation of cellular localization | 13.85% (9/65) | 2.97 | 2e-06 | 6.9e-05 |
GO:0009892 | negative regulation of metabolic process | 27.69% (18/65) | 1.78 | 2e-06 | 7.6e-05 |
GO:0035112 | genitalia morphogenesis | 4.62% (3/65) | 6.82 | 2e-06 | 7.6e-05 |
GO:0030242 | autophagy of peroxisome | 4.62% (3/65) | 6.82 | 2e-06 | 7.6e-05 |
GO:0006355 | regulation of DNA-templated transcription | 29.23% (19/65) | 1.7 | 3e-06 | 8.3e-05 |
GO:1905268 | negative regulation of chromatin organization | 4.62% (3/65) | 6.73 | 3e-06 | 8.5e-05 |
GO:2001141 | regulation of RNA biosynthetic process | 29.23% (19/65) | 1.69 | 3e-06 | 8.5e-05 |
GO:1903506 | regulation of nucleic acid-templated transcription | 29.23% (19/65) | 1.7 | 3e-06 | 8.6e-05 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 23.08% (15/65) | 2.01 | 3e-06 | 8.6e-05 |
GO:0006357 | regulation of transcription by RNA polymerase II | 18.46% (12/65) | 2.36 | 3e-06 | 9e-05 |
GO:0090304 | nucleic acid metabolic process | 27.69% (18/65) | 1.75 | 3e-06 | 9.6e-05 |
GO:0051052 | regulation of DNA metabolic process | 12.31% (8/65) | 3.13 | 4e-06 | 9.8e-05 |
GO:0016740 | transferase activity | 38.46% (25/65) | 1.35 | 4e-06 | 9.8e-05 |
GO:0005515 | protein binding | 66.15% (43/65) | 0.8 | 4e-06 | 9.9e-05 |
GO:0080135 | regulation of cellular response to stress | 13.85% (9/65) | 2.85 | 4e-06 | 0.000111 |
GO:0005694 | chromosome | 12.31% (8/65) | 3.08 | 5e-06 | 0.000123 |
GO:0007409 | axonogenesis | 6.15% (4/65) | 5.17 | 5e-06 | 0.000128 |
GO:0031324 | negative regulation of cellular metabolic process | 23.08% (15/65) | 1.95 | 5e-06 | 0.000129 |
GO:0022414 | reproductive process | 41.54% (27/65) | 1.24 | 5e-06 | 0.000138 |
GO:0032153 | cell division site | 6.15% (4/65) | 5.12 | 6e-06 | 0.000139 |
GO:1901363 | heterocyclic compound binding | 50.77% (33/65) | 1.04 | 5e-06 | 0.000139 |
GO:0004407 | histone deacetylase activity | 4.62% (3/65) | 6.42 | 6e-06 | 0.00014 |
GO:0033558 | protein lysine deacetylase activity | 4.62% (3/65) | 6.42 | 6e-06 | 0.00014 |
GO:0022402 | cell cycle process | 18.46% (12/65) | 2.27 | 6e-06 | 0.000141 |
GO:0051254 | positive regulation of RNA metabolic process | 21.54% (14/65) | 2.03 | 6e-06 | 0.000142 |
GO:0031326 | regulation of cellular biosynthetic process | 33.85% (22/65) | 1.45 | 6e-06 | 0.000142 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 23.08% (15/65) | 1.93 | 6e-06 | 0.000143 |
GO:0033036 | macromolecule localization | 21.54% (14/65) | 2.02 | 6e-06 | 0.000145 |
GO:0097159 | organic cyclic compound binding | 50.77% (33/65) | 1.03 | 6e-06 | 0.000148 |
GO:1903438 | positive regulation of mitotic cytokinetic process | 4.62% (3/65) | 6.36 | 7e-06 | 0.000149 |
GO:1903490 | positive regulation of mitotic cytokinesis | 4.62% (3/65) | 6.36 | 7e-06 | 0.000149 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 12.31% (8/65) | 3.0 | 7e-06 | 0.000159 |
GO:0040025 | vulval development | 4.62% (3/65) | 6.29 | 8e-06 | 0.000166 |
GO:0042149 | cellular response to glucose starvation | 4.62% (3/65) | 6.29 | 8e-06 | 0.000166 |
GO:0009272 | fungal-type cell wall biogenesis | 3.08% (2/65) | 8.65 | 8e-06 | 0.000171 |
GO:0120095 | vacuole-isolation membrane contact site | 3.08% (2/65) | 8.65 | 8e-06 | 0.000171 |
GO:0044260 | cellular macromolecule metabolic process | 27.69% (18/65) | 1.66 | 8e-06 | 0.000172 |
GO:0005488 | binding | 76.92% (50/65) | 0.62 | 8e-06 | 0.000173 |
GO:1903436 | regulation of mitotic cytokinetic process | 4.62% (3/65) | 6.17 | 1e-05 | 0.000204 |
GO:0009889 | regulation of biosynthetic process | 33.85% (22/65) | 1.4 | 1e-05 | 0.00021 |
GO:0032776 | DNA methylation on cytosine | 4.62% (3/65) | 6.12 | 1.1e-05 | 0.000222 |
GO:0032954 | regulation of cytokinetic process | 4.62% (3/65) | 6.12 | 1.1e-05 | 0.000222 |
GO:1902412 | regulation of mitotic cytokinesis | 4.62% (3/65) | 6.12 | 1.1e-05 | 0.000222 |
GO:0008150 | biological_process | 86.15% (56/65) | 0.49 | 1.2e-05 | 0.000237 |
GO:1902494 | catalytic complex | 20.0% (13/65) | 2.04 | 1.3e-05 | 0.000247 |
GO:0050793 | regulation of developmental process | 30.77% (20/65) | 1.48 | 1.4e-05 | 0.000281 |
GO:0000166 | nucleotide binding | 29.23% (19/65) | 1.53 | 1.6e-05 | 0.000298 |
GO:1901265 | nucleoside phosphate binding | 29.23% (19/65) | 1.53 | 1.6e-05 | 0.000298 |
GO:0019213 | deacetylase activity | 4.62% (3/65) | 5.96 | 1.6e-05 | 0.0003 |
GO:0051781 | positive regulation of cell division | 6.15% (4/65) | 4.74 | 1.6e-05 | 0.000301 |
GO:0008104 | protein localization | 18.46% (12/65) | 2.11 | 1.7e-05 | 0.00032 |
GO:0022411 | cellular component disassembly | 9.23% (6/65) | 3.47 | 1.7e-05 | 0.000322 |
GO:0007346 | regulation of mitotic cell cycle | 10.77% (7/65) | 3.07 | 2e-05 | 0.000367 |
GO:0070822 | Sin3-type complex | 4.62% (3/65) | 5.82 | 2.1e-05 | 0.000383 |
GO:0051641 | cellular localization | 21.54% (14/65) | 1.87 | 2.1e-05 | 0.000385 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 21.54% (14/65) | 1.85 | 2.4e-05 | 0.000436 |
GO:0048583 | regulation of response to stimulus | 33.85% (22/65) | 1.32 | 2.5e-05 | 0.000447 |
GO:0050891 | multicellular organismal water homeostasis | 4.62% (3/65) | 5.73 | 2.5e-05 | 0.00045 |
GO:0044238 | primary metabolic process | 56.92% (37/65) | 0.84 | 2.6e-05 | 0.000462 |
GO:0032501 | multicellular organismal process | 40.0% (26/65) | 1.15 | 2.7e-05 | 0.000467 |
GO:0000011 | vacuole inheritance | 3.08% (2/65) | 7.91 | 2.7e-05 | 0.000467 |
GO:0042981 | regulation of apoptotic process | 12.31% (8/65) | 2.71 | 2.9e-05 | 0.000499 |
GO:0051130 | positive regulation of cellular component organization | 12.31% (8/65) | 2.71 | 3e-05 | 0.000505 |
GO:0005575 | cellular_component | 84.62% (55/65) | 0.47 | 3.1e-05 | 0.000526 |
GO:0140513 | nuclear protein-containing complex | 16.92% (11/65) | 2.15 | 3.2e-05 | 0.000526 |
GO:0005654 | nucleoplasm | 18.46% (12/65) | 2.02 | 3.4e-05 | 0.000557 |
GO:0080134 | regulation of response to stress | 24.62% (16/65) | 1.63 | 3.7e-05 | 0.000606 |
GO:0051049 | regulation of transport | 16.92% (11/65) | 2.13 | 3.8e-05 | 0.000613 |
GO:0010964 | regulation of small non-coding RNA-mediated heterochromatin formation | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:0030033 | microvillus assembly | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:0090186 | regulation of pancreatic juice secretion | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:0090188 | negative regulation of pancreatic juice secretion | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:1905407 | regulation of creatine transmembrane transporter activity | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:1905408 | negative regulation of creatine transmembrane transporter activity | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:2000650 | negative regulation of sodium ion transmembrane transporter activity | 3.08% (2/65) | 7.65 | 4.1e-05 | 0.000618 |
GO:0098796 | membrane protein complex | 12.31% (8/65) | 2.66 | 3.8e-05 | 0.000618 |
GO:0016301 | kinase activity | 20.0% (13/65) | 1.89 | 3.8e-05 | 0.000621 |
GO:0045787 | positive regulation of cell cycle | 9.23% (6/65) | 3.24 | 4.2e-05 | 0.000633 |
GO:0006914 | autophagy | 7.69% (5/65) | 3.72 | 4e-05 | 0.000641 |
GO:0061919 | process utilizing autophagic mechanism | 7.69% (5/65) | 3.7 | 4.4e-05 | 0.000653 |
GO:0022607 | cellular component assembly | 21.54% (14/65) | 1.76 | 4.6e-05 | 0.000685 |
GO:0045893 | positive regulation of DNA-templated transcription | 18.46% (12/65) | 1.97 | 4.6e-05 | 0.000687 |
GO:0016192 | vesicle-mediated transport | 13.85% (9/65) | 2.4 | 4.9e-05 | 0.000718 |
GO:0010975 | regulation of neuron projection development | 7.69% (5/65) | 3.66 | 4.9e-05 | 0.000723 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 18.46% (12/65) | 1.96 | 5e-05 | 0.000726 |
GO:0043229 | intracellular organelle | 64.62% (42/65) | 0.69 | 5e-05 | 0.000727 |
GO:1902680 | positive regulation of RNA biosynthetic process | 18.46% (12/65) | 1.95 | 5.1e-05 | 0.000728 |
GO:0031329 | regulation of cellular catabolic process | 12.31% (8/65) | 2.6 | 5.1e-05 | 0.000729 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 16.92% (11/65) | 2.07 | 5.2e-05 | 0.000732 |
GO:0010819 | regulation of T cell chemotaxis | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0010820 | positive regulation of T cell chemotaxis | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0032528 | microvillus organization | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0038116 | chemokine (C-C motif) ligand 21 signaling pathway | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0038146 | chemokine (C-X-C motif) ligand 12 signaling pathway | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0070098 | chemokine-mediated signaling pathway | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0140131 | positive regulation of lymphocyte chemotaxis | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:1901623 | regulation of lymphocyte chemotaxis | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:2000403 | positive regulation of lymphocyte migration | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:2000406 | positive regulation of T cell migration | 3.08% (2/65) | 7.42 | 5.7e-05 | 0.000733 |
GO:0031175 | neuron projection development | 6.15% (4/65) | 4.3 | 5.3e-05 | 0.000741 |
GO:0006139 | nucleobase-containing compound metabolic process | 27.69% (18/65) | 1.46 | 5.4e-05 | 0.000749 |
GO:0043226 | organelle | 64.62% (42/65) | 0.69 | 5.9e-05 | 0.000751 |
GO:0006074 | (1->3)-beta-D-glucan metabolic process | 4.62% (3/65) | 5.33 | 5.9e-05 | 0.000754 |
GO:0032880 | regulation of protein localization | 10.77% (7/65) | 2.84 | 5.4e-05 | 0.000755 |
GO:0010941 | regulation of cell death | 15.38% (10/65) | 2.19 | 6e-05 | 0.000756 |
GO:0110165 | cellular anatomical entity | 83.08% (54/65) | 0.47 | 6.1e-05 | 0.000766 |
GO:0048856 | anatomical structure development | 41.54% (27/65) | 1.06 | 5.7e-05 | 0.000781 |
GO:0036094 | small molecule binding | 29.23% (19/65) | 1.38 | 6.3e-05 | 0.000784 |
GO:0044093 | positive regulation of molecular function | 12.31% (8/65) | 2.55 | 6.5e-05 | 0.000806 |
GO:2001020 | regulation of response to DNA damage stimulus | 7.69% (5/65) | 3.56 | 6.8e-05 | 0.000839 |
GO:0051179 | localization | 32.31% (21/65) | 1.27 | 6.8e-05 | 0.000842 |
GO:0006284 | base-excision repair | 4.62% (3/65) | 5.23 | 7.2e-05 | 0.000876 |
GO:0034728 | nucleosome organization | 6.15% (4/65) | 4.19 | 7.2e-05 | 0.000878 |
GO:0060627 | regulation of vesicle-mediated transport | 9.23% (6/65) | 3.09 | 7.7e-05 | 0.000903 |
GO:0048812 | neuron projection morphogenesis | 6.15% (4/65) | 4.17 | 7.6e-05 | 0.000905 |
GO:0006354 | DNA-templated transcription elongation | 4.62% (3/65) | 5.2 | 7.7e-05 | 0.000907 |
GO:0051683 | establishment of Golgi localization | 3.08% (2/65) | 7.23 | 7.6e-05 | 0.000907 |
GO:1902306 | negative regulation of sodium ion transmembrane transport | 3.08% (2/65) | 7.23 | 7.6e-05 | 0.000907 |
GO:0042594 | response to starvation | 12.31% (8/65) | 2.52 | 7.5e-05 | 0.000912 |
GO:0048858 | cell projection morphogenesis | 6.15% (4/65) | 4.14 | 8.1e-05 | 0.000934 |
GO:0120039 | plasma membrane bounded cell projection morphogenesis | 6.15% (4/65) | 4.14 | 8.1e-05 | 0.000934 |
GO:0035239 | tube morphogenesis | 6.15% (4/65) | 4.14 | 8.1e-05 | 0.000934 |
GO:0006807 | nitrogen compound metabolic process | 50.77% (33/65) | 0.86 | 8.2e-05 | 0.000943 |
GO:0042393 | histone binding | 7.69% (5/65) | 3.5 | 8.3e-05 | 0.000954 |
GO:0043067 | regulation of programmed cell death | 13.85% (9/65) | 2.29 | 8.6e-05 | 0.000972 |
GO:0006950 | response to stress | 50.77% (33/65) | 0.86 | 8.5e-05 | 0.000975 |
GO:1901987 | regulation of cell cycle phase transition | 9.23% (6/65) | 3.05 | 8.7e-05 | 0.000984 |
GO:0000148 | 1,3-beta-D-glucan synthase complex | 3.08% (2/65) | 7.06 | 9.7e-05 | 0.001082 |
GO:0003843 | 1,3-beta-D-glucan synthase activity | 3.08% (2/65) | 7.06 | 9.7e-05 | 0.001082 |
GO:0006075 | (1->3)-beta-D-glucan biosynthetic process | 3.08% (2/65) | 7.06 | 9.7e-05 | 0.001082 |
GO:0006325 | chromatin organization | 9.23% (6/65) | 3.02 | 0.0001 | 0.001105 |
GO:0060548 | negative regulation of cell death | 10.77% (7/65) | 2.7 | 0.000101 | 0.001111 |
GO:0031445 | regulation of heterochromatin formation | 4.62% (3/65) | 5.06 | 0.000102 | 0.001117 |
GO:0120261 | regulation of heterochromatin organization | 4.62% (3/65) | 5.06 | 0.000102 | 0.001117 |
GO:0009987 | cellular process | 75.38% (49/65) | 0.53 | 0.000106 | 0.001147 |
GO:0043066 | negative regulation of apoptotic process | 9.23% (6/65) | 3.0 | 0.000106 | 0.001151 |
GO:0006476 | protein deacetylation | 4.62% (3/65) | 5.04 | 0.000108 | 0.001163 |
GO:0006281 | DNA repair | 10.77% (7/65) | 2.68 | 0.000109 | 0.001164 |
GO:0032990 | cell part morphogenesis | 6.15% (4/65) | 4.01 | 0.000115 | 0.001214 |
GO:0060537 | muscle tissue development | 4.62% (3/65) | 5.01 | 0.000114 | 0.001216 |
GO:0051129 | negative regulation of cellular component organization | 9.23% (6/65) | 2.97 | 0.000117 | 0.00123 |
GO:0008152 | metabolic process | 63.08% (41/65) | 0.67 | 0.000119 | 0.001252 |
GO:0051253 | negative regulation of RNA metabolic process | 15.38% (10/65) | 2.07 | 0.000121 | 0.00126 |
GO:0048569 | post-embryonic animal organ development | 4.62% (3/65) | 4.96 | 0.000127 | 0.001318 |
GO:0046872 | metal ion binding | 27.69% (18/65) | 1.36 | 0.00013 | 0.00134 |
GO:0010628 | positive regulation of gene expression | 12.31% (8/65) | 2.39 | 0.000141 | 0.001451 |
GO:0000749 | response to pheromone triggering conjugation with cellular fusion | 3.08% (2/65) | 6.77 | 0.000148 | 0.001499 |
GO:0071444 | cellular response to pheromone | 3.08% (2/65) | 6.77 | 0.000148 | 0.001499 |
GO:0071561 | nucleus-vacuole junction | 3.08% (2/65) | 6.77 | 0.000148 | 0.001499 |
GO:0003674 | molecular_function | 81.54% (53/65) | 0.45 | 0.000147 | 0.001509 |
GO:0003824 | catalytic activity | 55.38% (36/65) | 0.75 | 0.000167 | 0.001679 |
GO:0032989 | cellular component morphogenesis | 6.15% (4/65) | 3.87 | 0.00017 | 0.001691 |
GO:0003008 | system process | 10.77% (7/65) | 2.58 | 0.000169 | 0.001697 |
GO:0043169 | cation binding | 27.69% (18/65) | 1.32 | 0.000173 | 0.001721 |
GO:0080165 | callose deposition in phloem sieve plate | 3.08% (2/65) | 6.65 | 0.000178 | 0.001741 |
GO:0061587 | transfer RNA gene-mediated silencing | 3.08% (2/65) | 6.65 | 0.000178 | 0.001741 |
GO:0036438 | maintenance of lens transparency | 3.08% (2/65) | 6.65 | 0.000178 | 0.001741 |
GO:0120035 | regulation of plasma membrane bounded cell projection organization | 7.69% (5/65) | 3.26 | 0.00018 | 0.001759 |
GO:0048871 | multicellular organismal homeostasis | 4.62% (3/65) | 4.77 | 0.000186 | 0.001808 |
GO:0043085 | positive regulation of catalytic activity | 9.23% (6/65) | 2.85 | 0.000187 | 0.001811 |
GO:1903047 | mitotic cell cycle process | 10.77% (7/65) | 2.53 | 0.000208 | 0.00199 |
GO:0050905 | neuromuscular process | 4.62% (3/65) | 4.71 | 0.000213 | 0.001993 |
GO:0035601 | protein deacylation | 4.62% (3/65) | 4.71 | 0.000213 | 0.001993 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 18.46% (12/65) | 1.74 | 0.000208 | 0.001997 |
GO:0071476 | cellular hypotonic response | 3.08% (2/65) | 6.53 | 0.00021 | 0.002002 |
GO:0051246 | regulation of protein metabolic process | 18.46% (12/65) | 1.74 | 0.000212 | 0.002005 |
GO:0031344 | regulation of cell projection organization | 7.69% (5/65) | 3.21 | 0.000212 | 0.002009 |
GO:0031667 | response to nutrient levels | 13.85% (9/65) | 2.11 | 0.000222 | 0.002077 |
GO:0003676 | nucleic acid binding | 32.31% (21/65) | 1.15 | 0.000232 | 0.002149 |
GO:0001525 | angiogenesis | 4.62% (3/65) | 4.67 | 0.000231 | 0.002151 |
GO:0098732 | macromolecule deacylation | 4.62% (3/65) | 4.65 | 0.000241 | 0.002223 |
GO:0055047 | generative cell mitosis | 3.08% (2/65) | 6.42 | 0.000245 | 0.002236 |
GO:0090556 | phosphatidylserine floppase activity | 3.08% (2/65) | 6.42 | 0.000245 | 0.002236 |
GO:0045892 | negative regulation of DNA-templated transcription | 13.85% (9/65) | 2.08 | 0.000253 | 0.002303 |
GO:0043167 | ion binding | 36.92% (24/65) | 1.02 | 0.000268 | 0.002404 |
GO:1902679 | negative regulation of RNA biosynthetic process | 13.85% (9/65) | 2.07 | 0.000268 | 0.002409 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 13.85% (9/65) | 2.07 | 0.000268 | 0.002409 |
GO:0043069 | negative regulation of programmed cell death | 9.23% (6/65) | 2.75 | 0.000267 | 0.002417 |
GO:0018193 | peptidyl-amino acid modification | 12.31% (8/65) | 2.24 | 0.000276 | 0.002422 |
GO:0009894 | regulation of catabolic process | 12.31% (8/65) | 2.24 | 0.000276 | 0.002422 |
GO:0003677 | DNA binding | 23.08% (15/65) | 1.45 | 0.000273 | 0.002427 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 12.31% (8/65) | 2.25 | 0.000272 | 0.002429 |
GO:0006338 | chromatin remodeling | 7.69% (5/65) | 3.13 | 0.000275 | 0.002431 |
GO:0097381 | photoreceptor disc membrane | 3.08% (2/65) | 6.33 | 0.000282 | 0.002436 |
GO:0140331 | aminophospholipid translocation | 3.08% (2/65) | 6.33 | 0.000282 | 0.002436 |
GO:0140346 | phosphatidylserine flippase activity | 3.08% (2/65) | 6.33 | 0.000282 | 0.002436 |
GO:0035329 | hippo signaling | 3.08% (2/65) | 6.33 | 0.000282 | 0.002436 |
GO:0016570 | histone modification | 9.23% (6/65) | 2.73 | 0.000291 | 0.002507 |
GO:0031346 | positive regulation of cell projection organization | 6.15% (4/65) | 3.64 | 0.000308 | 0.002642 |
GO:0140345 | phosphatidylcholine flippase activity | 3.08% (2/65) | 6.23 | 0.000322 | 0.002686 |
GO:0071564 | npBAF complex | 3.08% (2/65) | 6.23 | 0.000322 | 0.002686 |
GO:0010766 | negative regulation of sodium ion transport | 3.08% (2/65) | 6.23 | 0.000322 | 0.002686 |
GO:1901017 | negative regulation of potassium ion transmembrane transporter activity | 3.08% (2/65) | 6.23 | 0.000322 | 0.002686 |
GO:2000401 | regulation of lymphocyte migration | 3.08% (2/65) | 6.23 | 0.000322 | 0.002686 |
GO:2000404 | regulation of T cell migration | 3.08% (2/65) | 6.23 | 0.000322 | 0.002686 |
GO:0051234 | establishment of localization | 27.69% (18/65) | 1.26 | 0.000315 | 0.002688 |
GO:0008283 | cell population proliferation | 6.15% (4/65) | 3.62 | 0.000327 | 0.002696 |
GO:0071824 | protein-DNA complex subunit organization | 6.15% (4/65) | 3.62 | 0.000327 | 0.002696 |
GO:0033365 | protein localization to organelle | 10.77% (7/65) | 2.42 | 0.000325 | 0.002702 |
GO:0048729 | tissue morphogenesis | 6.15% (4/65) | 3.58 | 0.000359 | 0.002955 |
GO:0006305 | DNA alkylation | 4.62% (3/65) | 4.44 | 0.000367 | 0.00297 |
GO:0006306 | DNA methylation | 4.62% (3/65) | 4.44 | 0.000367 | 0.00297 |
GO:0071565 | nBAF complex | 3.08% (2/65) | 6.14 | 0.000364 | 0.002973 |
GO:0071677 | positive regulation of mononuclear cell migration | 3.08% (2/65) | 6.14 | 0.000364 | 0.002973 |
GO:0097193 | intrinsic apoptotic signaling pathway | 4.62% (3/65) | 4.42 | 0.00038 | 0.003065 |
GO:0009967 | positive regulation of signal transduction | 12.31% (8/65) | 2.17 | 0.000387 | 0.003114 |
GO:0015917 | aminophospholipid transport | 3.08% (2/65) | 6.06 | 0.000409 | 0.003257 |
GO:1990531 | phospholipid-translocating ATPase complex | 3.08% (2/65) | 6.06 | 0.000409 | 0.003257 |
GO:0000407 | phagophore assembly site | 3.08% (2/65) | 6.06 | 0.000409 | 0.003257 |
GO:0002682 | regulation of immune system process | 15.38% (10/65) | 1.85 | 0.000416 | 0.003294 |
GO:0050878 | regulation of body fluid levels | 4.62% (3/65) | 4.37 | 0.000421 | 0.003324 |
GO:0031669 | cellular response to nutrient levels | 10.77% (7/65) | 2.36 | 0.000425 | 0.003345 |
GO:0005856 | cytoskeleton | 9.23% (6/65) | 2.62 | 0.00044 | 0.003449 |
GO:0040012 | regulation of locomotion | 7.69% (5/65) | 2.98 | 0.000443 | 0.003464 |
GO:0015247 | aminophospholipid flippase activity | 3.08% (2/65) | 5.98 | 0.000457 | 0.003485 |
GO:0043267 | negative regulation of potassium ion transport | 3.08% (2/65) | 5.98 | 0.000457 | 0.003485 |
GO:0060457 | negative regulation of digestive system process | 3.08% (2/65) | 5.98 | 0.000457 | 0.003485 |
GO:1901380 | negative regulation of potassium ion transmembrane transport | 3.08% (2/65) | 5.98 | 0.000457 | 0.003485 |
GO:1903205 | regulation of hydrogen peroxide-induced cell death | 3.08% (2/65) | 5.98 | 0.000457 | 0.003485 |
GO:0045053 | protein retention in Golgi apparatus | 3.08% (2/65) | 5.98 | 0.000457 | 0.003485 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 4.62% (3/65) | 4.34 | 0.00045 | 0.003503 |
GO:0051094 | positive regulation of developmental process | 13.85% (9/65) | 1.96 | 0.000472 | 0.003586 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 4.62% (3/65) | 4.31 | 0.00048 | 0.003611 |
GO:0065009 | regulation of molecular function | 16.92% (11/65) | 1.71 | 0.000477 | 0.003613 |
GO:0030100 | regulation of endocytosis | 6.15% (4/65) | 3.47 | 0.00048 | 0.00362 |
GO:0003006 | developmental process involved in reproduction | 30.77% (20/65) | 1.11 | 0.000488 | 0.003655 |
GO:2000779 | regulation of double-strand break repair | 4.62% (3/65) | 4.29 | 0.000496 | 0.003703 |
GO:0060413 | atrial septum morphogenesis | 3.08% (2/65) | 5.91 | 0.000507 | 0.003739 |
GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 3.08% (2/65) | 5.91 | 0.000507 | 0.003739 |
GO:0006290 | pyrimidine dimer repair | 3.08% (2/65) | 5.91 | 0.000507 | 0.003739 |
GO:1901988 | negative regulation of cell cycle phase transition | 6.15% (4/65) | 3.45 | 0.000505 | 0.00376 |
GO:0040011 | locomotion | 7.69% (5/65) | 2.92 | 0.000534 | 0.003921 |
GO:0044728 | DNA methylation or demethylation | 4.62% (3/65) | 4.25 | 0.000545 | 0.003986 |
GO:0140657 | ATP-dependent activity | 10.77% (7/65) | 2.29 | 0.000552 | 0.004015 |
GO:0051239 | regulation of multicellular organismal process | 21.54% (14/65) | 1.42 | 0.000551 | 0.004018 |
GO:0000118 | histone deacetylase complex | 4.62% (3/65) | 4.23 | 0.000562 | 0.004029 |
GO:0048259 | regulation of receptor-mediated endocytosis | 4.62% (3/65) | 4.23 | 0.000562 | 0.004029 |
GO:0051302 | regulation of cell division | 7.69% (5/65) | 2.9 | 0.000565 | 0.004041 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 3.08% (2/65) | 5.84 | 0.00056 | 0.004047 |
GO:0034293 | sexual sporulation | 6.15% (4/65) | 3.41 | 0.000559 | 0.00405 |
GO:0018024 | histone-lysine N-methyltransferase activity | 4.62% (3/65) | 4.22 | 0.000579 | 0.004126 |
GO:0009846 | pollen germination | 6.15% (4/65) | 3.39 | 0.000587 | 0.004173 |
GO:0140014 | mitotic nuclear division | 3.08% (2/65) | 5.77 | 0.000616 | 0.004319 |
GO:0019236 | response to pheromone | 3.08% (2/65) | 5.77 | 0.000616 | 0.004319 |
GO:0006337 | nucleosome disassembly | 3.08% (2/65) | 5.77 | 0.000616 | 0.004319 |
GO:0052742 | phosphatidylinositol kinase activity | 3.08% (2/65) | 5.77 | 0.000616 | 0.004319 |
GO:0031328 | positive regulation of cellular biosynthetic process | 18.46% (12/65) | 1.56 | 0.000632 | 0.00442 |
GO:0018105 | peptidyl-serine phosphorylation | 6.15% (4/65) | 3.36 | 0.000637 | 0.004438 |
GO:0023056 | positive regulation of signaling | 12.31% (8/65) | 2.06 | 0.000644 | 0.004477 |
GO:0009913 | epidermal cell differentiation | 4.62% (3/65) | 4.16 | 0.000651 | 0.00451 |
GO:0010506 | regulation of autophagy | 6.15% (4/65) | 3.34 | 0.000668 | 0.00461 |
GO:0060411 | cardiac septum morphogenesis | 3.08% (2/65) | 5.71 | 0.000674 | 0.004622 |
GO:0044058 | regulation of digestive system process | 3.08% (2/65) | 5.71 | 0.000674 | 0.004622 |
GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 4.62% (3/65) | 4.13 | 0.000689 | 0.004716 |
GO:0010647 | positive regulation of cell communication | 12.31% (8/65) | 2.04 | 0.000697 | 0.004753 |
GO:0071852 | fungal-type cell wall organization or biogenesis | 3.08% (2/65) | 5.65 | 0.000734 | 0.00496 |
GO:0009891 | positive regulation of biosynthetic process | 18.46% (12/65) | 1.54 | 0.000737 | 0.004966 |
GO:0018209 | peptidyl-serine modification | 6.15% (4/65) | 3.31 | 0.000733 | 0.004967 |
GO:0009991 | response to extracellular stimulus | 13.85% (9/65) | 1.87 | 0.000732 | 0.00498 |
GO:0045807 | positive regulation of endocytosis | 4.62% (3/65) | 4.09 | 0.000749 | 0.005032 |
GO:1903008 | organelle disassembly | 4.62% (3/65) | 4.08 | 0.00077 | 0.005156 |
GO:0003682 | chromatin binding | 9.23% (6/65) | 2.46 | 0.000773 | 0.00516 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 13.85% (9/65) | 1.86 | 0.000776 | 0.005162 |
GO:0008360 | regulation of cell shape | 4.62% (3/65) | 4.06 | 0.000791 | 0.005249 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 3.08% (2/65) | 5.59 | 0.000797 | 0.005256 |
GO:0010452 | histone H3-K36 methylation | 3.08% (2/65) | 5.59 | 0.000797 | 0.005256 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 6.15% (4/65) | 3.27 | 0.000814 | 0.005324 |
GO:0016278 | lysine N-methyltransferase activity | 4.62% (3/65) | 4.05 | 0.000812 | 0.005327 |
GO:0016279 | protein-lysine N-methyltransferase activity | 4.62% (3/65) | 4.05 | 0.000812 | 0.005327 |
GO:0051046 | regulation of secretion | 6.15% (4/65) | 3.25 | 0.000839 | 0.005468 |
GO:0006304 | DNA modification | 4.62% (3/65) | 4.02 | 0.000856 | 0.005516 |
GO:0032784 | regulation of DNA-templated transcription elongation | 4.62% (3/65) | 4.02 | 0.000856 | 0.005516 |
GO:0002687 | positive regulation of leukocyte migration | 3.08% (2/65) | 5.53 | 0.000862 | 0.005523 |
GO:0046831 | regulation of RNA export from nucleus | 3.08% (2/65) | 5.53 | 0.000862 | 0.005523 |
GO:0009267 | cellular response to starvation | 9.23% (6/65) | 2.43 | 0.000856 | 0.005544 |
GO:0071704 | organic substance metabolic process | 56.92% (37/65) | 0.62 | 0.000854 | 0.005549 |
GO:0031331 | positive regulation of cellular catabolic process | 7.69% (5/65) | 2.76 | 0.000873 | 0.005572 |
GO:0048584 | positive regulation of response to stimulus | 18.46% (12/65) | 1.51 | 0.000878 | 0.005588 |
GO:0030154 | cell differentiation | 15.38% (10/65) | 1.7 | 0.000932 | 0.00585 |
GO:0090306 | meiotic spindle assembly | 3.08% (2/65) | 5.48 | 0.00093 | 0.005856 |
GO:0051645 | Golgi localization | 3.08% (2/65) | 5.48 | 0.00093 | 0.005856 |
GO:0032239 | regulation of nucleobase-containing compound transport | 3.08% (2/65) | 5.48 | 0.00093 | 0.005856 |
GO:0010508 | positive regulation of autophagy | 4.62% (3/65) | 3.98 | 0.000925 | 0.005873 |
GO:0007059 | chromosome segregation | 4.62% (3/65) | 3.96 | 0.000973 | 0.006088 |
GO:0090555 | phosphatidylethanolamine flippase activity | 3.08% (2/65) | 5.42 | 0.001001 | 0.006159 |
GO:0016514 | SWI/SNF complex | 3.08% (2/65) | 5.42 | 0.001001 | 0.006159 |
GO:1900745 | positive regulation of p38MAPK cascade | 3.08% (2/65) | 5.42 | 0.001001 | 0.006159 |
GO:2001032 | regulation of double-strand break repair via nonhomologous end joining | 3.08% (2/65) | 5.42 | 0.001001 | 0.006159 |
GO:0071889 | 14-3-3 protein binding | 3.08% (2/65) | 5.42 | 0.001001 | 0.006159 |
GO:0042054 | histone methyltransferase activity | 4.62% (3/65) | 3.95 | 0.000997 | 0.006223 |
GO:0035556 | intracellular signal transduction | 12.31% (8/65) | 1.95 | 0.00103 | 0.006321 |
GO:0005815 | microtubule organizing center | 7.69% (5/65) | 2.7 | 0.001061 | 0.006495 |
GO:0002688 | regulation of leukocyte chemotaxis | 3.08% (2/65) | 5.37 | 0.001074 | 0.006517 |
GO:1901031 | regulation of response to reactive oxygen species | 3.08% (2/65) | 5.37 | 0.001074 | 0.006517 |
GO:0048308 | organelle inheritance | 3.08% (2/65) | 5.37 | 0.001074 | 0.006517 |
GO:0043933 | protein-containing complex organization | 13.85% (9/65) | 1.79 | 0.001091 | 0.0066 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 13.85% (9/65) | 1.79 | 0.001095 | 0.006612 |
GO:0071482 | cellular response to light stimulus | 7.69% (5/65) | 2.68 | 0.001102 | 0.006636 |
GO:0032386 | regulation of intracellular transport | 6.15% (4/65) | 3.14 | 0.001113 | 0.006661 |
GO:0090068 | positive regulation of cell cycle process | 6.15% (4/65) | 3.14 | 0.001113 | 0.006661 |
GO:0071675 | regulation of mononuclear cell migration | 3.08% (2/65) | 5.33 | 0.001149 | 0.006843 |
GO:1902305 | regulation of sodium ion transmembrane transport | 3.08% (2/65) | 5.33 | 0.001149 | 0.006843 |
GO:0048514 | blood vessel morphogenesis | 3.08% (2/65) | 5.28 | 0.001227 | 0.007268 |
GO:0014706 | striated muscle tissue development | 3.08% (2/65) | 5.28 | 0.001227 | 0.007268 |
GO:0032388 | positive regulation of intracellular transport | 4.62% (3/65) | 3.83 | 0.001263 | 0.007459 |
GO:0000785 | chromatin | 7.69% (5/65) | 2.63 | 0.001302 | 0.007672 |
GO:0090554 | phosphatidylcholine floppase activity | 3.08% (2/65) | 5.23 | 0.001308 | 0.007682 |
GO:0043087 | regulation of GTPase activity | 4.62% (3/65) | 3.81 | 0.001321 | 0.00774 |
GO:0051286 | cell tip | 6.15% (4/65) | 3.07 | 0.001338 | 0.00782 |
GO:0009504 | cell plate | 4.62% (3/65) | 3.79 | 0.001351 | 0.007871 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 15.38% (10/65) | 1.62 | 0.001358 | 0.007875 |
GO:0010948 | negative regulation of cell cycle process | 6.15% (4/65) | 3.07 | 0.001355 | 0.007879 |
GO:0031982 | vesicle | 16.92% (11/65) | 1.52 | 0.001366 | 0.0079 |
GO:0009556 | microsporogenesis | 4.62% (3/65) | 3.78 | 0.001381 | 0.00792 |
GO:0097190 | apoptotic signaling pathway | 4.62% (3/65) | 3.78 | 0.001381 | 0.00792 |
GO:0120031 | plasma membrane bounded cell projection assembly | 4.62% (3/65) | 3.78 | 0.001381 | 0.00792 |
GO:1900744 | regulation of p38MAPK cascade | 3.08% (2/65) | 5.19 | 0.001391 | 0.007957 |
GO:0043130 | ubiquitin binding | 4.62% (3/65) | 3.77 | 0.001411 | 0.008032 |
GO:0046822 | regulation of nucleocytoplasmic transport | 4.62% (3/65) | 3.77 | 0.001411 | 0.008032 |
GO:0046483 | heterocycle metabolic process | 27.69% (18/65) | 1.07 | 0.001436 | 0.008155 |
GO:0012506 | vesicle membrane | 9.23% (6/65) | 2.28 | 0.001454 | 0.008237 |
GO:0032986 | protein-DNA complex disassembly | 3.08% (2/65) | 5.14 | 0.001476 | 0.008316 |
GO:0034644 | cellular response to UV | 4.62% (3/65) | 3.75 | 0.001473 | 0.008322 |
GO:0001708 | cell fate specification | 4.62% (3/65) | 3.73 | 0.001537 | 0.008616 |
GO:0043934 | sporulation | 6.15% (4/65) | 3.02 | 0.001536 | 0.008634 |
GO:0006368 | transcription elongation by RNA polymerase II promoter | 3.08% (2/65) | 5.1 | 0.001564 | 0.008655 |
GO:0070577 | lysine-acetylated histone binding | 3.08% (2/65) | 5.1 | 0.001564 | 0.008655 |
GO:0140033 | acetylation-dependent protein binding | 3.08% (2/65) | 5.1 | 0.001564 | 0.008655 |
GO:1903201 | regulation of oxidative stress-induced cell death | 3.08% (2/65) | 5.1 | 0.001564 | 0.008655 |
GO:2000369 | regulation of clathrin-dependent endocytosis | 3.08% (2/65) | 5.1 | 0.001564 | 0.008655 |
GO:0008276 | protein methyltransferase activity | 4.62% (3/65) | 3.72 | 0.00157 | 0.008666 |
GO:0060187 | cell pole | 6.15% (4/65) | 3.01 | 0.001575 | 0.008672 |
GO:0030334 | regulation of cell migration | 6.15% (4/65) | 3.0 | 0.001594 | 0.008713 |
GO:0071214 | cellular response to abiotic stimulus | 10.77% (7/65) | 2.03 | 0.001594 | 0.008733 |
GO:0104004 | cellular response to environmental stimulus | 10.77% (7/65) | 2.03 | 0.001594 | 0.008733 |
GO:0030031 | cell projection assembly | 4.62% (3/65) | 3.71 | 0.001603 | 0.008739 |
GO:0035172 | hemocyte proliferation | 1.54% (1/65) | 9.23 | 0.001663 | 0.008849 |
GO:1901255 | nucleotide-excision repair involved in interstrand cross-link repair | 1.54% (1/65) | 9.23 | 0.001663 | 0.008849 |
GO:1905767 | regulation of double-stranded telomeric DNA binding | 1.54% (1/65) | 9.23 | 0.001663 | 0.008849 |
GO:1905768 | negative regulation of double-stranded telomeric DNA binding | 1.54% (1/65) | 9.23 | 0.001663 | 0.008849 |
GO:0070124 | mitochondrial translational initiation | 1.54% (1/65) | 9.23 | 0.001663 | 0.008849 |
GO:0060872 | semicircular canal development | 1.54% (1/65) | 9.23 | 0.001663 | 0.008849 |
GO:0006810 | transport | 24.62% (16/65) | 1.15 | 0.001629 | 0.008862 |
GO:0005524 | ATP binding | 15.38% (10/65) | 1.59 | 0.001634 | 0.008867 |
GO:1901564 | organonitrogen compound metabolic process | 38.46% (25/65) | 0.82 | 0.001677 | 0.008904 |
GO:0140333 | glycerophospholipid flippase activity | 3.08% (2/65) | 5.06 | 0.001654 | 0.00893 |
GO:0000212 | meiotic spindle organization | 3.08% (2/65) | 5.06 | 0.001654 | 0.00893 |
GO:0007154 | cell communication | 12.31% (8/65) | 1.84 | 0.001699 | 0.008996 |
GO:0031327 | negative regulation of cellular biosynthetic process | 13.85% (9/65) | 1.7 | 0.001716 | 0.009044 |
GO:2000145 | regulation of cell motility | 6.15% (4/65) | 2.97 | 0.001713 | 0.00905 |
GO:0031668 | cellular response to extracellular stimulus | 10.77% (7/65) | 2.01 | 0.001758 | 0.009157 |
GO:0030427 | site of polarized growth | 6.15% (4/65) | 2.97 | 0.001754 | 0.009158 |
GO:0140327 | flippase activity | 3.08% (2/65) | 5.02 | 0.001747 | 0.009161 |
GO:0030900 | forebrain development | 3.08% (2/65) | 5.02 | 0.001747 | 0.009161 |
GO:0031347 | regulation of defense response | 15.38% (10/65) | 1.58 | 0.001753 | 0.009171 |
GO:1905634 | regulation of protein localization to chromatin | 3.08% (2/65) | 4.98 | 0.001842 | 0.009391 |
GO:0008217 | regulation of blood pressure | 3.08% (2/65) | 4.98 | 0.001842 | 0.009391 |
GO:0005930 | axoneme | 3.08% (2/65) | 4.98 | 0.001842 | 0.009391 |
GO:0044232 | organelle membrane contact site | 3.08% (2/65) | 4.98 | 0.001842 | 0.009391 |
GO:0043014 | alpha-tubulin binding | 3.08% (2/65) | 4.98 | 0.001842 | 0.009391 |
GO:0051321 | meiotic cell cycle | 6.15% (4/65) | 2.95 | 0.001817 | 0.009397 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 6.15% (4/65) | 2.95 | 0.001817 | 0.009397 |
GO:0008170 | N-methyltransferase activity | 4.62% (3/65) | 3.65 | 0.00181 | 0.009402 |
GO:0071478 | cellular response to radiation | 7.69% (5/65) | 2.52 | 0.001841 | 0.0095 |
GO:1990351 | transporter complex | 4.62% (3/65) | 3.63 | 0.001882 | 0.009576 |
GO:0031410 | cytoplasmic vesicle | 15.38% (10/65) | 1.56 | 0.001892 | 0.009602 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 6.15% (4/65) | 2.93 | 0.001926 | 0.009752 |
GO:0045332 | phospholipid translocation | 3.08% (2/65) | 4.95 | 0.001939 | 0.009798 |
GO:0010562 | positive regulation of phosphorus metabolic process | 6.15% (4/65) | 2.91 | 0.001993 | 0.010022 |
GO:0045937 | positive regulation of phosphate metabolic process | 6.15% (4/65) | 2.91 | 0.001993 | 0.010022 |
GO:0002685 | regulation of leukocyte migration | 3.08% (2/65) | 4.91 | 0.002039 | 0.01014 |
GO:0007231 | osmosensory signaling pathway | 3.08% (2/65) | 4.91 | 0.002039 | 0.01014 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 3.08% (2/65) | 4.91 | 0.002039 | 0.01014 |
GO:0016787 | hydrolase activity | 23.08% (15/65) | 1.17 | 0.002026 | 0.010167 |
GO:0009890 | negative regulation of biosynthetic process | 13.85% (9/65) | 1.66 | 0.002032 | 0.010176 |
GO:0032182 | ubiquitin-like protein binding | 4.62% (3/65) | 3.58 | 0.002071 | 0.010278 |
GO:0051640 | organelle localization | 7.69% (5/65) | 2.47 | 0.002097 | 0.010382 |
GO:1990234 | transferase complex | 10.77% (7/65) | 1.96 | 0.002116 | 0.010451 |
GO:0031156 | regulation of sorocarp development | 3.08% (2/65) | 4.87 | 0.002141 | 0.010506 |
GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 3.08% (2/65) | 4.87 | 0.002141 | 0.010506 |
GO:0034641 | cellular nitrogen compound metabolic process | 27.69% (18/65) | 1.02 | 0.002138 | 0.010538 |
GO:0009896 | positive regulation of catabolic process | 7.69% (5/65) | 2.46 | 0.002182 | 0.01066 |
GO:0051493 | regulation of cytoskeleton organization | 6.15% (4/65) | 2.88 | 0.00218 | 0.01067 |
GO:0000018 | regulation of DNA recombination | 4.62% (3/65) | 3.55 | 0.00219 | 0.010676 |
GO:0050896 | response to stimulus | 56.92% (37/65) | 0.56 | 0.002229 | 0.010841 |
GO:0071496 | cellular response to external stimulus | 10.77% (7/65) | 1.94 | 0.002274 | 0.01101 |
GO:0030104 | water homeostasis | 4.62% (3/65) | 3.53 | 0.002272 | 0.011025 |
GO:0034204 | lipid translocation | 3.08% (2/65) | 4.81 | 0.002353 | 0.01122 |
GO:0097035 | regulation of membrane lipid distribution | 3.08% (2/65) | 4.81 | 0.002353 | 0.01122 |
GO:0001709 | cell fate determination | 3.08% (2/65) | 4.81 | 0.002353 | 0.01122 |
GO:0048562 | embryonic organ morphogenesis | 3.08% (2/65) | 4.81 | 0.002353 | 0.01122 |
GO:0034214 | protein hexamerization | 3.08% (2/65) | 4.81 | 0.002353 | 0.01122 |
GO:0045786 | negative regulation of cell cycle | 6.15% (4/65) | 2.85 | 0.002327 | 0.01122 |
GO:0097708 | intracellular vesicle | 15.38% (10/65) | 1.52 | 0.002323 | 0.011222 |
GO:0007165 | signal transduction | 23.08% (15/65) | 1.15 | 0.002402 | 0.011379 |
GO:0030855 | epithelial cell differentiation | 4.62% (3/65) | 3.5 | 0.002398 | 0.011386 |
GO:0006282 | regulation of DNA repair | 4.62% (3/65) | 3.5 | 0.002398 | 0.011386 |
GO:0065008 | regulation of biological quality | 24.62% (16/65) | 1.09 | 0.002454 | 0.011602 |
GO:0031399 | regulation of protein modification process | 10.77% (7/65) | 1.92 | 0.002465 | 0.01163 |
GO:0035295 | tube development | 4.62% (3/65) | 3.48 | 0.002528 | 0.011902 |
GO:2000241 | regulation of reproductive process | 13.85% (9/65) | 1.61 | 0.002554 | 0.011999 |
GO:0140328 | floppase activity | 3.08% (2/65) | 4.74 | 0.002574 | 0.01204 |
GO:1901703 | protein localization involved in auxin polar transport | 3.08% (2/65) | 4.74 | 0.002574 | 0.01204 |
GO:0022603 | regulation of anatomical structure morphogenesis | 10.77% (7/65) | 1.91 | 0.002591 | 0.012095 |
GO:0042325 | regulation of phosphorylation | 7.69% (5/65) | 2.39 | 0.002646 | 0.012322 |
GO:0043268 | positive regulation of potassium ion transport | 3.08% (2/65) | 4.71 | 0.002688 | 0.012415 |
GO:0050921 | positive regulation of chemotaxis | 3.08% (2/65) | 4.71 | 0.002688 | 0.012415 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.08% (2/65) | 4.71 | 0.002688 | 0.012415 |
GO:0070201 | regulation of establishment of protein localization | 6.15% (4/65) | 2.8 | 0.002671 | 0.012416 |
GO:0004672 | protein kinase activity | 13.85% (9/65) | 1.6 | 0.002713 | 0.012504 |
GO:0007010 | cytoskeleton organization | 9.23% (6/65) | 2.1 | 0.00274 | 0.012602 |
GO:0140030 | modification-dependent protein binding | 4.62% (3/65) | 3.43 | 0.002755 | 0.012644 |
GO:0043168 | anion binding | 20.0% (13/65) | 1.24 | 0.002782 | 0.012742 |
GO:2000177 | regulation of neural precursor cell proliferation | 3.08% (2/65) | 4.68 | 0.002805 | 0.012792 |
GO:0019221 | cytokine-mediated signaling pathway | 3.08% (2/65) | 4.68 | 0.002805 | 0.012792 |
GO:0032559 | adenyl ribonucleotide binding | 15.38% (10/65) | 1.48 | 0.00283 | 0.012883 |
GO:0002009 | morphogenesis of an epithelium | 4.62% (3/65) | 3.42 | 0.002849 | 0.012941 |
GO:0032984 | protein-containing complex disassembly | 4.62% (3/65) | 3.41 | 0.002897 | 0.013131 |
GO:0002028 | regulation of sodium ion transport | 3.08% (2/65) | 4.65 | 0.002924 | 0.013144 |
GO:0018107 | peptidyl-threonine phosphorylation | 3.08% (2/65) | 4.65 | 0.002924 | 0.013144 |
GO:0018210 | peptidyl-threonine modification | 3.08% (2/65) | 4.65 | 0.002924 | 0.013144 |
GO:0051048 | negative regulation of secretion | 3.08% (2/65) | 4.65 | 0.002924 | 0.013144 |
GO:0030554 | adenyl nucleotide binding | 15.38% (10/65) | 1.47 | 0.002936 | 0.013173 |
GO:0007049 | cell cycle | 7.69% (5/65) | 2.35 | 0.002977 | 0.013332 |
GO:0006892 | post-Golgi vesicle-mediated transport | 4.62% (3/65) | 3.39 | 0.002994 | 0.013378 |
GO:0140097 | catalytic activity, acting on DNA | 6.15% (4/65) | 2.75 | 0.003018 | 0.013461 |
GO:0006298 | mismatch repair | 3.08% (2/65) | 4.62 | 0.003045 | 0.013523 |
GO:0070887 | cellular response to chemical stimulus | 18.46% (12/65) | 1.3 | 0.00304 | 0.013528 |
GO:0001832 | blastocyst growth | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0005726 | perichromatin fibrils | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0007403 | glial cell fate determination | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0035886 | vascular associated smooth muscle cell differentiation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0035887 | aortic smooth muscle cell differentiation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0043974 | histone H3-K27 acetylation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0060318 | definitive erythrocyte differentiation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0060343 | trabecula formation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0060347 | heart trabecula formation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0061626 | pharyngeal arch artery morphogenesis | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0070307 | lens fiber cell development | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:1902895 | positive regulation of miRNA transcription | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0010789 | meiotic sister chromatid cohesion involved in meiosis I | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0034263 | positive regulation of autophagy in response to ER overload | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:1990604 | IRE1-TRAF2-ASK1 complex | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0031494 | regulation of mating type switching | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0031496 | positive regulation of mating type switching | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0002196 | Ser-tRNA(Ala) hydrolase activity | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0070143 | mitochondrial alanyl-tRNA aminoacylation | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0140018 | regulation of cytoplasmic translational fidelity | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0000110 | nucleotide-excision repair factor 1 complex | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0140504 | microlipophagy | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:0016929 | deSUMOylase activity | 1.54% (1/65) | 8.23 | 0.003323 | 0.013998 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 4.62% (3/65) | 3.33 | 0.003349 | 0.01408 |
GO:0050877 | nervous system process | 6.15% (4/65) | 2.72 | 0.003203 | 0.014169 |
GO:0040008 | regulation of growth | 13.85% (9/65) | 1.56 | 0.003201 | 0.014191 |
GO:0048193 | Golgi vesicle transport | 6.15% (4/65) | 2.7 | 0.003395 | 0.014247 |
GO:1900407 | regulation of cellular response to oxidative stress | 3.08% (2/65) | 4.53 | 0.003422 | 0.014332 |
GO:0008525 | phosphatidylcholine transporter activity | 3.08% (2/65) | 4.56 | 0.003294 | 0.014513 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 9.23% (6/65) | 2.05 | 0.003292 | 0.014535 |
GO:0005829 | cytosol | 27.69% (18/65) | 0.96 | 0.003506 | 0.014657 |
GO:0140326 | ATPase-coupled intramembrane lipid transporter activity | 3.08% (2/65) | 4.5 | 0.003552 | 0.014766 |
GO:0016575 | histone deacetylation | 3.08% (2/65) | 4.5 | 0.003552 | 0.014766 |
GO:0050772 | positive regulation of axonogenesis | 3.08% (2/65) | 4.5 | 0.003552 | 0.014766 |
GO:0043414 | macromolecule methylation | 6.15% (4/65) | 2.68 | 0.003561 | 0.014775 |
GO:1904063 | negative regulation of cation transmembrane transport | 3.08% (2/65) | 4.48 | 0.003685 | 0.01509 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.08% (2/65) | 4.48 | 0.003685 | 0.01509 |
GO:0044237 | cellular metabolic process | 50.77% (33/65) | 0.58 | 0.003676 | 0.015108 |
GO:0000280 | nuclear division | 4.62% (3/65) | 3.29 | 0.003673 | 0.015126 |
GO:0051273 | beta-glucan metabolic process | 4.62% (3/65) | 3.29 | 0.003673 | 0.015126 |
GO:0030335 | positive regulation of cell migration | 4.62% (3/65) | 3.29 | 0.003673 | 0.015126 |
GO:0043410 | positive regulation of MAPK cascade | 4.62% (3/65) | 3.29 | 0.003673 | 0.015126 |
GO:2000147 | positive regulation of cell motility | 4.62% (3/65) | 3.27 | 0.003785 | 0.015415 |
GO:0050767 | regulation of neurogenesis | 4.62% (3/65) | 3.27 | 0.003785 | 0.015415 |
GO:0032956 | regulation of actin cytoskeleton organization | 4.62% (3/65) | 3.27 | 0.003785 | 0.015415 |
GO:0140303 | intramembrane lipid transporter activity | 3.08% (2/65) | 4.45 | 0.00382 | 0.015527 |
GO:0048236 | plant-type sporogenesis | 4.62% (3/65) | 3.25 | 0.003958 | 0.016027 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 3.08% (2/65) | 4.42 | 0.003957 | 0.016055 |
GO:0008023 | transcription elongation factor complex | 3.08% (2/65) | 4.4 | 0.004097 | 0.01653 |
GO:0051219 | phosphoprotein binding | 3.08% (2/65) | 4.4 | 0.004097 | 0.01653 |
GO:0045911 | positive regulation of DNA recombination | 3.08% (2/65) | 4.37 | 0.004239 | 0.017071 |
GO:0051656 | establishment of organelle localization | 6.15% (4/65) | 2.6 | 0.004358 | 0.017517 |
GO:0006971 | hypotonic response | 3.08% (2/65) | 4.35 | 0.004383 | 0.017587 |
GO:0006468 | protein phosphorylation | 12.31% (8/65) | 1.61 | 0.004418 | 0.017695 |
GO:0016310 | phosphorylation | 13.85% (9/65) | 1.49 | 0.004447 | 0.017778 |
GO:0035639 | purine ribonucleoside triphosphate binding | 15.38% (10/65) | 1.39 | 0.004483 | 0.017892 |
GO:0030111 | regulation of Wnt signaling pathway | 4.62% (3/65) | 3.18 | 0.004502 | 0.017936 |
GO:0051649 | establishment of localization in cell | 12.31% (8/65) | 1.6 | 0.00464 | 0.018452 |
GO:0097485 | neuron projection guidance | 3.08% (2/65) | 4.3 | 0.004677 | 0.018567 |
GO:0045930 | negative regulation of mitotic cell cycle | 4.62% (3/65) | 3.16 | 0.004694 | 0.018597 |
GO:0032970 | regulation of actin filament-based process | 4.62% (3/65) | 3.15 | 0.004758 | 0.01882 |
GO:0016323 | basolateral plasma membrane | 3.08% (2/65) | 4.25 | 0.004981 | 0.018855 |
GO:1901799 | negative regulation of proteasomal protein catabolic process | 3.08% (2/65) | 4.25 | 0.004981 | 0.018855 |
GO:0003151 | outflow tract morphogenesis | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0043696 | dedifferentiation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0043697 | cell dedifferentiation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0051145 | smooth muscle cell differentiation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:2000630 | positive regulation of miRNA metabolic process | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0072765 | centromere localization | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0098653 | centromere clustering | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:1990571 | meiotic centromere clustering | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0036290 | protein trans-autophosphorylation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0098592 | cytoplasmic side of apical plasma membrane | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0004813 | alanine-tRNA ligase activity | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0015278 | calcium-release channel activity | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0097198 | histone H3-K36 trimethylation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0061819 | telomeric DNA-containing double minutes formation | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0070522 | ERCC4-ERCC1 complex | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:1905764 | regulation of protection from non-homologous end joining at telomere | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:1905765 | negative regulation of protection from non-homologous end joining at telomere | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0097680 | double-strand break repair via classical nonhomologous end joining | 1.54% (1/65) | 7.65 | 0.004981 | 0.018918 |
GO:0000287 | magnesium ion binding | 6.15% (4/65) | 2.54 | 0.005007 | 0.01892 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 3.08% (2/65) | 4.28 | 0.004828 | 0.019062 |
GO:0040017 | positive regulation of locomotion | 4.62% (3/65) | 3.12 | 0.005091 | 0.019203 |
GO:0070647 | protein modification by small protein conjugation or removal | 10.77% (7/65) | 1.74 | 0.004887 | 0.019261 |
GO:0032154 | cleavage furrow | 3.08% (2/65) | 4.23 | 0.005136 | 0.01931 |
GO:1901016 | regulation of potassium ion transmembrane transporter activity | 3.08% (2/65) | 4.23 | 0.005136 | 0.01931 |
GO:0016070 | RNA metabolic process | 15.38% (10/65) | 1.37 | 0.004968 | 0.019543 |
GO:0045597 | positive regulation of cell differentiation | 6.15% (4/65) | 2.52 | 0.005222 | 0.0196 |
GO:0060562 | epithelial tube morphogenesis | 3.08% (2/65) | 4.21 | 0.005294 | 0.0198 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 3.08% (2/65) | 4.21 | 0.005294 | 0.0198 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 3.08% (2/65) | 4.19 | 0.005453 | 0.020363 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 4.62% (3/65) | 3.08 | 0.005507 | 0.020528 |
GO:0050790 | regulation of catalytic activity | 10.77% (7/65) | 1.7 | 0.00559 | 0.020804 |
GO:0098813 | nuclear chromosome segregation | 3.08% (2/65) | 4.17 | 0.005615 | 0.020861 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.62% (3/65) | 3.06 | 0.00565 | 0.020956 |
GO:0003697 | single-stranded DNA binding | 4.62% (3/65) | 3.06 | 0.005723 | 0.021189 |
GO:0051960 | regulation of nervous system development | 4.62% (3/65) | 3.05 | 0.005796 | 0.021352 |
GO:0007051 | spindle organization | 4.62% (3/65) | 3.05 | 0.005796 | 0.021352 |
GO:0034502 | protein localization to chromosome | 3.08% (2/65) | 4.14 | 0.005779 | 0.021362 |
GO:0000775 | chromosome, centromeric region | 3.08% (2/65) | 4.1 | 0.006114 | 0.022485 |
GO:0030336 | negative regulation of cell migration | 3.08% (2/65) | 4.08 | 0.006284 | 0.023035 |
GO:0006661 | phosphatidylinositol biosynthetic process | 3.08% (2/65) | 4.08 | 0.006284 | 0.023035 |
GO:0048730 | epidermis morphogenesis | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0072429 | response to intra-S DNA damage checkpoint signaling | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0035004 | phosphatidylinositol 3-kinase activity | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0001400 | mating projection base | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0007116 | regulation of cell budding | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:1901900 | regulation of protein localization to cell division site | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:1901901 | regulation of protein localization to cell division site involved in cytokinesis | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:1903501 | positive regulation of mitotic actomyosin contractile ring assembly | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:2000433 | positive regulation of cytokinesis, actomyosin contractile ring assembly | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:1904354 | negative regulation of telomere capping | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:1904742 | regulation of telomeric DNA binding | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:1904743 | negative regulation of telomeric DNA binding | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0045501 | regulation of sevenless signaling pathway | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0045874 | positive regulation of sevenless signaling pathway | 1.54% (1/65) | 7.23 | 0.006635 | 0.023351 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 6.15% (4/65) | 2.44 | 0.006394 | 0.023399 |
GO:0006725 | cellular aromatic compound metabolic process | 27.69% (18/65) | 0.88 | 0.006417 | 0.023445 |
GO:0005548 | phospholipid transporter activity | 3.08% (2/65) | 4.06 | 0.006457 | 0.023512 |
GO:0048768 | root hair cell tip growth | 3.08% (2/65) | 4.06 | 0.006457 | 0.023512 |
GO:0030659 | cytoplasmic vesicle membrane | 7.69% (5/65) | 2.09 | 0.006494 | 0.023607 |
GO:0072594 | establishment of protein localization to organelle | 6.15% (4/65) | 2.42 | 0.006751 | 0.02372 |
GO:0140535 | intracellular protein-containing complex | 9.23% (6/65) | 1.83 | 0.006793 | 0.023831 |
GO:1902531 | regulation of intracellular signal transduction | 9.23% (6/65) | 1.83 | 0.006825 | 0.023904 |
GO:2000146 | negative regulation of cell motility | 3.08% (2/65) | 4.04 | 0.006632 | 0.024029 |
GO:0032507 | maintenance of protein location in cell | 3.08% (2/65) | 4.04 | 0.006632 | 0.024029 |
GO:0018205 | peptidyl-lysine modification | 6.15% (4/65) | 2.4 | 0.007014 | 0.024526 |
GO:0000151 | ubiquitin ligase complex | 6.15% (4/65) | 2.4 | 0.007067 | 0.024674 |
GO:0051336 | regulation of hydrolase activity | 6.15% (4/65) | 2.39 | 0.007175 | 0.024852 |
GO:0015914 | phospholipid transport | 3.08% (2/65) | 3.98 | 0.007169 | 0.024871 |
GO:0001894 | tissue homeostasis | 3.08% (2/65) | 3.98 | 0.007169 | 0.024871 |
GO:0043547 | positive regulation of GTPase activity | 3.08% (2/65) | 3.98 | 0.007169 | 0.024871 |
GO:0050727 | regulation of inflammatory response | 3.08% (2/65) | 3.98 | 0.007169 | 0.024871 |
GO:0006401 | RNA catabolic process | 4.62% (3/65) | 2.93 | 0.007207 | 0.024926 |
GO:0060966 | regulation of gene silencing by RNA | 3.08% (2/65) | 3.97 | 0.007352 | 0.025229 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 3.08% (2/65) | 3.97 | 0.007352 | 0.025229 |
GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 3.08% (2/65) | 3.97 | 0.007352 | 0.025229 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 3.08% (2/65) | 3.97 | 0.007352 | 0.025229 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 3.08% (2/65) | 3.97 | 0.007352 | 0.025229 |
GO:0006302 | double-strand break repair | 4.62% (3/65) | 2.92 | 0.007461 | 0.025561 |
GO:0005768 | endosome | 10.77% (7/65) | 1.62 | 0.007477 | 0.025578 |
GO:0090734 | site of DNA damage | 3.08% (2/65) | 3.95 | 0.007538 | 0.025745 |
GO:0032555 | purine ribonucleotide binding | 15.38% (10/65) | 1.28 | 0.00756 | 0.025781 |
GO:0001098 | basal transcription machinery binding | 3.08% (2/65) | 3.93 | 0.007725 | 0.026223 |
GO:0070063 | RNA polymerase binding | 3.08% (2/65) | 3.93 | 0.007725 | 0.026223 |
GO:0045185 | maintenance of protein location | 3.08% (2/65) | 3.93 | 0.007725 | 0.026223 |
GO:0003712 | transcription coregulator activity | 6.15% (4/65) | 2.36 | 0.007786 | 0.026388 |
GO:0017076 | purine nucleotide binding | 15.38% (10/65) | 1.27 | 0.007896 | 0.02672 |
GO:1901379 | regulation of potassium ion transmembrane transport | 3.08% (2/65) | 3.91 | 0.007915 | 0.026743 |
GO:0019220 | regulation of phosphate metabolic process | 7.69% (5/65) | 2.01 | 0.008045 | 0.02714 |
GO:0006508 | proteolysis | 10.77% (7/65) | 1.6 | 0.008068 | 0.027178 |
GO:0008586 | imaginal disc-derived wing vein morphogenesis | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0035116 | embryonic hindlimb morphogenesis | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0140463 | chromatin-protein adaptor activity | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0036498 | IRE1-mediated unfolded protein response | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0031441 | negative regulation of mRNA 3'-end processing | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:1900364 | negative regulation of mRNA polyadenylation | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0031321 | ascospore-type prospore assembly | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0070296 | sarcoplasmic reticulum calcium ion transport | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0031942 | i-AAA complex | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:1904505 | regulation of telomere maintenance in response to DNA damage | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:1904506 | negative regulation of telomere maintenance in response to DNA damage | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0033687 | osteoblast proliferation | 1.54% (1/65) | 6.91 | 0.008287 | 0.027209 |
GO:0050770 | regulation of axonogenesis | 3.08% (2/65) | 3.87 | 0.008301 | 0.027211 |
GO:0006334 | nucleosome assembly | 3.08% (2/65) | 3.89 | 0.008107 | 0.027224 |
GO:1902882 | regulation of response to oxidative stress | 3.08% (2/65) | 3.89 | 0.008107 | 0.027224 |
GO:0051247 | positive regulation of protein metabolic process | 9.23% (6/65) | 1.77 | 0.008324 | 0.027249 |
GO:0048285 | organelle fission | 4.62% (3/65) | 2.87 | 0.008162 | 0.027367 |
GO:0048471 | perinuclear region of cytoplasm | 6.15% (4/65) | 2.34 | 0.008192 | 0.027427 |
GO:0047485 | protein N-terminus binding | 3.08% (2/65) | 3.86 | 0.008496 | 0.027771 |
GO:0051174 | regulation of phosphorus metabolic process | 7.69% (5/65) | 1.99 | 0.008584 | 0.028015 |
GO:0051240 | positive regulation of multicellular organismal process | 9.23% (6/65) | 1.75 | 0.008771 | 0.028543 |
GO:0019899 | enzyme binding | 13.85% (9/65) | 1.34 | 0.008771 | 0.028582 |
GO:0051051 | negative regulation of transport | 4.62% (3/65) | 2.83 | 0.008806 | 0.028612 |
GO:0008168 | methyltransferase activity | 6.15% (4/65) | 2.3 | 0.008858 | 0.028739 |
GO:0007033 | vacuole organization | 4.62% (3/65) | 2.82 | 0.0089 | 0.028792 |
GO:0040013 | negative regulation of locomotion | 3.08% (2/65) | 3.82 | 0.008894 | 0.028815 |
GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 3.08% (2/65) | 3.81 | 0.009096 | 0.02934 |
GO:0032553 | ribonucleotide binding | 15.38% (10/65) | 1.24 | 0.009093 | 0.029372 |
GO:0032410 | negative regulation of transporter activity | 3.08% (2/65) | 3.79 | 0.009301 | 0.029911 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 3.08% (2/65) | 3.79 | 0.009301 | 0.029911 |
GO:0007032 | endosome organization | 3.08% (2/65) | 3.77 | 0.009507 | 0.03053 |
GO:0040029 | epigenetic regulation of gene expression | 4.62% (3/65) | 2.78 | 0.009578 | 0.030713 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0035137 | hindlimb morphogenesis | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0036335 | intestinal stem cell homeostasis | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0070983 | dendrite guidance | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0035622 | intrahepatic bile duct development | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0061009 | common bile duct development | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0045041 | protein import into mitochondrial intermembrane space | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0016321 | female meiosis chromosome segregation | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0006362 | transcription elongation by RNA polymerase I | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0042675 | compound eye cone cell differentiation | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0045676 | regulation of R7 cell differentiation | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0110116 | regulation of compound eye photoreceptor cell differentiation | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:1905011 | transmembrane phosphate ion transport from cytosol to vacuole | 1.54% (1/65) | 6.65 | 0.009937 | 0.031007 |
GO:0005798 | Golgi-associated vesicle | 3.08% (2/65) | 3.76 | 0.009715 | 0.031017 |
GO:0072655 | establishment of protein localization to mitochondrion | 3.08% (2/65) | 3.76 | 0.009715 | 0.031017 |
GO:0051276 | chromosome organization | 6.15% (4/65) | 2.25 | 0.009955 | 0.03102 |
GO:0051668 | localization within membrane | 6.15% (4/65) | 2.27 | 0.009689 | 0.031026 |
GO:0042327 | positive regulation of phosphorylation | 4.62% (3/65) | 2.76 | 0.009978 | 0.031047 |
GO:0050776 | regulation of immune response | 10.77% (7/65) | 1.55 | 0.009767 | 0.031139 |
GO:0016741 | transferase activity, transferring one-carbon groups | 6.15% (4/65) | 2.25 | 0.010022 | 0.031142 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 3.08% (2/65) | 3.74 | 0.009925 | 0.031552 |
GO:0051495 | positive regulation of cytoskeleton organization | 3.08% (2/65) | 3.74 | 0.009925 | 0.031552 |
GO:0045324 | late endosome to vacuole transport | 3.08% (2/65) | 3.71 | 0.010352 | 0.032074 |
GO:0070585 | protein localization to mitochondrion | 3.08% (2/65) | 3.71 | 0.010352 | 0.032074 |
GO:0061136 | regulation of proteasomal protein catabolic process | 4.62% (3/65) | 2.73 | 0.010492 | 0.032463 |
GO:0031048 | small non-coding RNA-dependent heterochromatin formation | 3.08% (2/65) | 3.68 | 0.010786 | 0.033327 |
GO:2001251 | negative regulation of chromosome organization | 3.08% (2/65) | 3.66 | 0.011006 | 0.03396 |
GO:0060284 | regulation of cell development | 4.62% (3/65) | 2.7 | 0.011237 | 0.034526 |
GO:0007612 | learning | 3.08% (2/65) | 3.65 | 0.011229 | 0.034549 |
GO:0050708 | regulation of protein secretion | 3.08% (2/65) | 3.65 | 0.011229 | 0.034549 |
GO:0031055 | chromatin remodeling at centromere | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:1900247 | regulation of cytoplasmic translational elongation | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0051283 | negative regulation of sequestering of calcium ion | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0034401 | obsolete chromatin organization involved in regulation of transcription | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:1903499 | regulation of mitotic actomyosin contractile ring assembly | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:2000431 | regulation of cytokinesis, actomyosin contractile ring assembly | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0035694 | mitochondrial protein catabolic process | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0048886 | neuromast hair cell differentiation | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0048903 | anterior lateral line neuromast hair cell differentiation | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0030716 | oocyte fate determination | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0030296 | protein tyrosine kinase activator activity | 1.54% (1/65) | 6.42 | 0.011583 | 0.034861 |
GO:0043408 | regulation of MAPK cascade | 4.62% (3/65) | 2.68 | 0.011676 | 0.035092 |
GO:0050920 | regulation of chemotaxis | 3.08% (2/65) | 3.63 | 0.011453 | 0.03514 |
GO:0015031 | protein transport | 9.23% (6/65) | 1.66 | 0.011545 | 0.035375 |
GO:0000077 | DNA damage checkpoint signaling | 3.08% (2/65) | 3.6 | 0.011907 | 0.035689 |
GO:0098687 | chromosomal region | 4.62% (3/65) | 2.67 | 0.011899 | 0.035714 |
GO:0004386 | helicase activity | 4.62% (3/65) | 2.66 | 0.012012 | 0.035905 |
GO:0001558 | regulation of cell growth | 7.69% (5/65) | 1.87 | 0.012004 | 0.035929 |
GO:0006886 | intracellular protein transport | 7.69% (5/65) | 1.86 | 0.01212 | 0.036179 |
GO:0016236 | macroautophagy | 3.08% (2/65) | 3.59 | 0.012137 | 0.036182 |
GO:0030177 | positive regulation of Wnt signaling pathway | 3.08% (2/65) | 3.57 | 0.012369 | 0.036824 |
GO:0034766 | negative regulation of ion transmembrane transport | 3.08% (2/65) | 3.56 | 0.012603 | 0.03747 |
GO:0030667 | secretory granule membrane | 3.08% (2/65) | 3.55 | 0.012839 | 0.038017 |
GO:0080113 | regulation of seed growth | 3.08% (2/65) | 3.55 | 0.012839 | 0.038017 |
GO:0072686 | mitotic spindle | 3.08% (2/65) | 3.55 | 0.012839 | 0.038017 |
GO:0007406 | negative regulation of neuroblast proliferation | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0046020 | obsolete negative regulation of transcription from RNA polymerase II promoter by pheromones | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0090537 | CERF complex | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:1902893 | regulation of miRNA transcription | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0033017 | sarcoplasmic reticulum membrane | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0097553 | calcium ion transmembrane import into cytosol | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0016576 | obsolete histone dephosphorylation | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:2000051 | negative regulation of non-canonical Wnt signaling pathway | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 1.54% (1/65) | 6.23 | 0.013227 | 0.038494 |
GO:0007034 | vacuolar transport | 4.62% (3/65) | 2.61 | 0.01329 | 0.038626 |
GO:0006289 | nucleotide-excision repair | 3.08% (2/65) | 3.53 | 0.013077 | 0.03867 |
GO:0097367 | carbohydrate derivative binding | 15.38% (10/65) | 1.16 | 0.013154 | 0.038845 |
GO:0044248 | cellular catabolic process | 15.38% (10/65) | 1.16 | 0.013186 | 0.038887 |
GO:0034763 | negative regulation of transmembrane transport | 3.08% (2/65) | 3.5 | 0.013559 | 0.03925 |
GO:0043271 | negative regulation of ion transport | 3.08% (2/65) | 3.5 | 0.013559 | 0.03925 |
GO:0019898 | extrinsic component of membrane | 4.62% (3/65) | 2.6 | 0.013531 | 0.039273 |
GO:0046488 | phosphatidylinositol metabolic process | 3.08% (2/65) | 3.49 | 0.013802 | 0.039799 |
GO:0006839 | mitochondrial transport | 3.08% (2/65) | 3.49 | 0.013802 | 0.039799 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4.62% (3/65) | 2.59 | 0.013774 | 0.039821 |
GO:0032259 | methylation | 6.15% (4/65) | 2.11 | 0.013849 | 0.039883 |
GO:0010927 | cellular component assembly involved in morphogenesis | 4.62% (3/65) | 2.58 | 0.013896 | 0.039913 |
GO:0002684 | positive regulation of immune system process | 7.69% (5/65) | 1.81 | 0.013892 | 0.039952 |
GO:0032101 | regulation of response to external stimulus | 12.31% (8/65) | 1.33 | 0.013965 | 0.040057 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 3.08% (2/65) | 3.46 | 0.014295 | 0.040952 |
GO:0051223 | regulation of protein transport | 4.62% (3/65) | 2.56 | 0.014392 | 0.041176 |
GO:0070603 | SWI/SNF superfamily-type complex | 3.08% (2/65) | 3.45 | 0.014544 | 0.04129 |
GO:0051651 | maintenance of location in cell | 3.08% (2/65) | 3.45 | 0.014544 | 0.04129 |
GO:0042770 | signal transduction in response to DNA damage | 3.08% (2/65) | 3.45 | 0.014544 | 0.04129 |
GO:0048638 | regulation of developmental growth | 9.23% (6/65) | 1.59 | 0.014454 | 0.041301 |
GO:0010228 | vegetative to reproductive phase transition of meristem | 4.62% (3/65) | 2.56 | 0.014518 | 0.041374 |
GO:0031984 | organelle subcompartment | 9.23% (6/65) | 1.59 | 0.014509 | 0.041402 |
GO:0035060 | brahma complex | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0048844 | artery morphogenesis | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0016344 | meiotic chromosome movement towards spindle pole | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0046833 | positive regulation of RNA export from nucleus | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0021680 | cerebellar Purkinje cell layer development | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0002574 | thrombocyte differentiation | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0004430 | 1-phosphatidylinositol 4-kinase activity | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:2000786 | positive regulation of autophagosome assembly | 1.54% (1/65) | 6.06 | 0.014869 | 0.041568 |
GO:0098797 | plasma membrane protein complex | 3.08% (2/65) | 3.44 | 0.014795 | 0.041895 |
GO:0051101 | regulation of DNA binding | 3.08% (2/65) | 3.44 | 0.014795 | 0.041895 |
GO:0061982 | meiosis I cell cycle process | 3.08% (2/65) | 3.42 | 0.015049 | 0.042018 |
GO:0000226 | microtubule cytoskeleton organization | 6.15% (4/65) | 2.07 | 0.01513 | 0.042191 |
GO:0032872 | regulation of stress-activated MAPK cascade | 3.08% (2/65) | 3.41 | 0.015303 | 0.042514 |
GO:0030496 | midbody | 3.08% (2/65) | 3.41 | 0.015303 | 0.042514 |
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 3.08% (2/65) | 3.41 | 0.015303 | 0.042514 |
GO:0045184 | establishment of protein localization | 9.23% (6/65) | 1.57 | 0.01534 | 0.042561 |
GO:0030162 | regulation of proteolysis | 6.15% (4/65) | 2.07 | 0.015394 | 0.042659 |
GO:0032411 | positive regulation of transporter activity | 3.08% (2/65) | 3.4 | 0.01556 | 0.04301 |
GO:0043549 | regulation of kinase activity | 4.62% (3/65) | 2.52 | 0.015544 | 0.04302 |
GO:1901360 | organic cyclic compound metabolic process | 27.69% (18/65) | 0.75 | 0.015957 | 0.044052 |
GO:0016586 | RSC-type complex | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0060281 | regulation of oocyte development | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0034704 | calcium channel complex | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0033561 | regulation of water loss via skin | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0048853 | forebrain morphogenesis | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0061436 | establishment of skin barrier | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:1900186 | negative regulation of clathrin-dependent endocytosis | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0010304 | PSII associated light-harvesting complex II catabolic process | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0048916 | posterior lateral line development | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0032790 | ribosome disassembly | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0050265 | RNA uridylyltransferase activity | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0044011 | single-species biofilm formation on inanimate substrate | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0090605 | submerged biofilm formation | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0090609 | single-species submerged biofilm formation | 1.54% (1/65) | 5.91 | 0.016507 | 0.044565 |
GO:0016050 | vesicle organization | 4.62% (3/65) | 2.5 | 0.016206 | 0.044684 |
GO:0031401 | positive regulation of protein modification process | 6.15% (4/65) | 2.04 | 0.01639 | 0.045134 |
GO:0043523 | regulation of neuron apoptotic process | 3.08% (2/65) | 3.34 | 0.016872 | 0.045493 |
GO:0005737 | cytoplasm | 18.46% (12/65) | 0.98 | 0.01691 | 0.045542 |
GO:0030099 | myeloid cell differentiation | 3.08% (2/65) | 3.31 | 0.017409 | 0.046714 |
GO:0060249 | anatomical structure homeostasis | 3.08% (2/65) | 3.31 | 0.017409 | 0.046714 |
GO:0031570 | DNA integrity checkpoint signaling | 3.08% (2/65) | 3.31 | 0.017409 | 0.046714 |
GO:0003407 | neural retina development | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0007474 | imaginal disc-derived wing vein specification | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0060194 | regulation of antisense RNA transcription | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0060195 | negative regulation of antisense RNA transcription | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0060976 | coronary vasculature development | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0061780 | mitotic cohesin loading | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0071921 | cohesin loading | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0048482 | plant ovule morphogenesis | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:1905879 | regulation of oogenesis | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:2001137 | positive regulation of endocytic recycling | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0106074 | aminoacyl-tRNA metabolism involved in translational fidelity | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0034497 | protein localization to phagophore assembly site | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0046532 | regulation of photoreceptor cell differentiation | 1.54% (1/65) | 5.77 | 0.018143 | 0.047639 |
GO:0050769 | positive regulation of neurogenesis | 3.08% (2/65) | 3.28 | 0.018229 | 0.047807 |
GO:0015629 | actin cytoskeleton | 3.08% (2/65) | 3.29 | 0.017954 | 0.048 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 3.08% (2/65) | 3.29 | 0.017954 | 0.048 |
GO:0016485 | protein processing | 3.08% (2/65) | 3.29 | 0.017954 | 0.048 |
GO:0045595 | regulation of cell differentiation | 7.69% (5/65) | 1.72 | 0.018098 | 0.048326 |
GO:0051274 | beta-glucan biosynthetic process | 3.08% (2/65) | 3.27 | 0.018505 | 0.048417 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 3.08% (2/65) | 3.27 | 0.018505 | 0.048417 |
GO:0019783 | ubiquitin-like protein peptidase activity | 3.08% (2/65) | 3.25 | 0.018784 | 0.049088 |
GO:0010996 | response to auditory stimulus | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0060052 | neurofilament cytoskeleton organization | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0070821 | tertiary granule membrane | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0008623 | CHRAC | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0030902 | hindbrain development | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0070987 | error-free translesion synthesis | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0071922 | regulation of cohesin loading | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0016593 | Cdc73/Paf1 complex | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0035441 | cell migration involved in vasculogenesis | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0048332 | mesoderm morphogenesis | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0060039 | pericardium development | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0060669 | embryonic placenta morphogenesis | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0097676 | histone H3-K36 dimethylation | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0000014 | single-stranded DNA endodeoxyribonuclease activity | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0035063 | nuclear speck organization | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0035092 | sperm DNA condensation | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0042710 | biofilm formation | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0044010 | single-species biofilm formation | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0098630 | aggregation of unicellular organisms | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |
GO:0098743 | cell aggregation | 1.54% (1/65) | 5.65 | 0.019776 | 0.049962 |